Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-02-21FDA Approved: XELJANZ XR — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ XR (tofacitinib) submitted by Pfizer, updating the extended-release formulation's label.
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib [Phase 4]
A Phase 4 trial evaluating the Shingrix vaccine in patients with moderate to severe ulcerative colitis on tofacitinib was terminated; result…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis [Phase 4]
A Phase 4 trial of endovenous corticosteroid pulses in moderate ulcerative colitis was terminated. Results have been posted.
-
FDA approval · 2025-02-18FDA Approved: MESALAMINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's original ANDA for Mesalamine, a generic mesalamine product. This approval authorizes marketing for ulcerative colitis,…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD) [NA]
This registry entry notes a recruiting study evaluating psychologist-administered and self-administered cognitive behavioral therapy for anx…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002) [Phase 1]
Phase 1 single-dose study of Tulisokibart (MK-7240) in healthy Chinese participants has completed.
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Effect of Anti-inflammatory Diet in Patients With Inflammatory Bowel Disease [NA]
A clinical trial is evaluating the effects of an anti-inflammatory diet in patients with inflammatory bowel diseases and is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Special Physical Exercises as a Therapeutic Intervention for Inflammatory Bowel Disease [NA]
Clinical trial evaluating special physical exercises as a therapeutic intervention for inflammatory bowel disease has completed. The study e…
-
FDA approval · 2025-02-13FDA Approved: PREDNISOLONE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental Abbreviated New Drug Application for a generic prednisolone product from PAI Holdings/PAI Pharma, signaling regu…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Nutritional Counseling Impact on Ulcerative Colitis Patients [NA]
This clinical trial update reports on a completed study evaluating the impact of nutritional counseling on patients with Ulcerative Colitis.
-
FDA approval · 2025-02-12FDA Approved: SELARSDI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for SELARSDI (ustekinumab-aeKn) from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease [Phase 4]
Phase 4 trial evaluating vedolizumab in ulcerative colitis and Crohn's disease has completed and results have been posted by Takeda.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Clinical Database of Colorectal Robotic Surgery
This clinical trial database entry for colorectal robotic surgery, sponsored by Institut du Cancer de Montpellier – Val d'Aurelle, lists col…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis [Phase 1]
Phase 1 study of ExoFlo for medically refractory ulcerative colitis has been terminated; no efficacy results are provided in this update.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating hydroxychloroquine for ulcerative colitis in African American and Hispanic participants; the study …
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Renal and Urinary Manifestations of Chronic Inflammatory Bowel Diseases.
This clinical trial from IRCCS Azienda Ospedaliero-Universitaria di Bologna investigates renal and urinary manifestations in chronic inflamm…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: TITRATE (inducTIon for acuTe ulceRATivE Colitis) [Phase 4]
The TITRATE Phase 4 trial for induction in acute ulcerative colitis, sponsored by AMC-UvA, has been terminated.
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis [Phase 3]
This document provides a clinical trial update for a Phase 3 long-term extension study of filgotinib in adults with ulcerative colitis, whic…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Alpha Lipoic Acid in Ulcerative Colitis [NA]
A clinical trial update indicates recruitment for a study evaluating Alpha Lipoic Acid in Ulcerative Colitis, sponsored by Tanta University.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative Colitis [Phase 1]
A Phase 1 study evaluating JNJ-66525433 in healthy participants and in patients with Ulcerative Colitis has been terminated.
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Long-term Treatment With Ustekinumab in Patients With Crohn's Disease and Ulcerative Colitis: a Cohort Study
Clinical trial update describing a long-term, cohort study of ustekinumab in Crohn's disease and ulcerative colitis, with recruitment ongoin…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Physical Activity and Sedentary Behaviour in Patients With Inflammatory Bowel Disease [NA]
This completed trial evaluated physical activity and sedentary behavior in patients with inflammatory bowel disease to assess feasibility an…
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: National GMA Post-market Clinical Follow-up Study (GRACE)
Post-market clinical follow-up study (GRACE) sponsored by Adacyte Therapeutics SL, currently recruiting participants for Crohn's disease and…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Role of Roflumilast in Ulcerative Colitis [Phase 4]
Phase 4 study investigating roflumilast for ulcerative colitis has completed. It represents a late-stage evaluation of this PDE4 inhibitor i…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC)
A multi-center cohort study for acute severe ulcerative colitis (MASCC) sponsored by Johns Hopkins University has completed.